Nektar Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results

SAN FRANCISCO , Feb. 25, 2021 /PRNewswire/ —  Nektar Therapeutics  (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2020.     Cash and investments in marketable securities at December 31, 2020 were approximately $1.2 billion as compared


Get every new post delivered right to your inbox.

Original Source

Related Posts

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5107